Usual Adult Dose for Acromegaly:
Initial dose: 90 mg, by deep subcutaneous injection, every 4 weeks for 3 months
Comments:
-The goal of treatment is to reduce growth hormone (GH) and insulin-like growth factor (IGF-1) levels to normal.
-Adjust dose after initial 3 months.
-No dose adjustment is required for elderly patients.
Use: Long-term treatment of acromegalic patients who have had an inadequate response to surgery and/or radiotherapy, or for whom surgery and/or radiotherapy is not an option.
Usual Adult Dose for Neuroendocrine Carcinoma:
120 mg, by deep subcutaneous injection, every 4 weeks
Comments: No dose adjustment is required for elderly patients.
Use: Treatment of patients with unresectable, well or moderately-differentiated, locally advanced, or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to improve progression-free survival.
Usual Adult Dose for Carcinoid Syndrome:
120 mg by deep subcutaneous injection every 4 weeks
Comments: If patients are already being treated for GEP-NETs, do not administer an additional dose for the treatment of carcinoid syndrome.
Use: For the treatment of carcinoid syndrome; when used, it reduces the frequency of short-acting somatostatin analog rescue therapy.
 Detailed Somatuline Depot dosage information
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment for your Somatuline Depo injection.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
